global pharm limited
global pharm limited Company Information
Company Number
07139443
Next Accounts
Feb 2025
Directors
Shareholders
wajid hussain
amjid rasool
Group Structure
View All
Industry
Dispensing chemist in specialised stores
Registered Address
1 oakley street, thorpe, wakefield, west yorskhire, WF3 3DX
Website
www.globalpharmholdings.comglobal pharm limited Estimated Valuation
Pomanda estimates the enterprise value of GLOBAL PHARM LIMITED at £759.5k based on a Turnover of £2.3m and 0.33x industry multiple (adjusted for size and gross margin).
global pharm limited Estimated Valuation
Pomanda estimates the enterprise value of GLOBAL PHARM LIMITED at £247.2k based on an EBITDA of £61.7k and a 4.01x industry multiple (adjusted for size and gross margin).
global pharm limited Estimated Valuation
Pomanda estimates the enterprise value of GLOBAL PHARM LIMITED at £769.6k based on Net Assets of £343.4k and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Global Pharm Limited Overview
Global Pharm Limited is a live company located in wakefield, WF3 3DX with a Companies House number of 07139443. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in January 2010, it's largest shareholder is wajid hussain with a 50% stake. Global Pharm Limited is a established, small sized company, Pomanda has estimated its turnover at £2.3m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Global Pharm Limited Health Check
Pomanda's financial health check has awarded Global Pharm Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
4 Regular
4 Weak
Size
annual sales of £2.3m, make it smaller than the average company (£11.5m)
- Global Pharm Limited
£11.5m - Industry AVG
Growth
3 year (CAGR) sales growth of 16%, show it is growing at a faster rate (6.1%)
- Global Pharm Limited
6.1% - Industry AVG
Production
with a gross margin of 27.4%, this company has a comparable cost of product (32.6%)
- Global Pharm Limited
32.6% - Industry AVG
Profitability
an operating margin of 2.6% make it as profitable than the average company (3.2%)
- Global Pharm Limited
3.2% - Industry AVG
Employees
with 19 employees, this is below the industry average (75)
19 - Global Pharm Limited
75 - Industry AVG
Pay Structure
on an average salary of £25.3k, the company has an equivalent pay structure (£25.3k)
- Global Pharm Limited
£25.3k - Industry AVG
Efficiency
resulting in sales per employee of £122.9k, this is equally as efficient (£144k)
- Global Pharm Limited
£144k - Industry AVG
Debtor Days
it gets paid by customers after 68 days, this is later than average (30 days)
- Global Pharm Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 20 days, this is quicker than average (65 days)
- Global Pharm Limited
65 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Global Pharm Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Global Pharm Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 21.4%, this is a lower level of debt than the average (57.6%)
21.4% - Global Pharm Limited
57.6% - Industry AVG
GLOBAL PHARM LIMITED financials
Global Pharm Limited's latest turnover from May 2023 is estimated at £2.3 million and the company has net assets of £343.4 thousand. According to their latest financial statements, Global Pharm Limited has 19 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||||
| Other Income Or Grants | |||||||||||||
| Cost Of Sales | |||||||||||||
| Gross Profit | |||||||||||||
| Admin Expenses | |||||||||||||
| Operating Profit | |||||||||||||
| Interest Payable | |||||||||||||
| Interest Receivable | |||||||||||||
| Pre-Tax Profit | |||||||||||||
| Tax | |||||||||||||
| Profit After Tax | |||||||||||||
| Dividends Paid | |||||||||||||
| Retained Profit | |||||||||||||
| Employee Costs | |||||||||||||
| Number Of Employees | 19 | 15 | 15 | 19 | |||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,176 | 1,032 | 0 | 0 | 4,553 | 8,738 | 12,985 | 17,313 | 410 | 2,372 | 4,334 | 6,080 | 7,600 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20,000 | 24,000 | 28,000 | 32,000 | 36,000 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 1,176 | 1,032 | 0 | 0 | 4,553 | 8,738 | 12,985 | 17,313 | 20,410 | 26,372 | 32,334 | 38,080 | 43,600 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12,960 | 11,273 | 6,637 | 5,890 | 3,650 |
| Trade Debtors | 435,665 | 428,488 | 453,905 | 289,933 | 257,688 | 212,858 | 112,336 | 58,647 | 3,356 | 3,356 | 8,259 | 51,465 | 50,030 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15,609 | 32,990 | 27,138 | 28,123 | 31,649 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 435,665 | 428,488 | 453,905 | 289,933 | 257,688 | 212,858 | 112,336 | 58,647 | 31,925 | 47,619 | 42,034 | 85,478 | 85,329 |
| total assets | 436,841 | 429,520 | 453,905 | 289,933 | 262,241 | 221,596 | 125,321 | 75,960 | 52,335 | 73,991 | 74,368 | 123,558 | 128,929 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 93,427 | 132,399 | 194,087 | 136,837 | 144,171 | 110,355 | 45,583 | 78,312 | 55,595 | 41,377 | 30,685 | 72,903 | 110,158 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 93,427 | 132,399 | 194,087 | 136,837 | 144,171 | 110,355 | 45,583 | 78,312 | 55,595 | 41,377 | 30,685 | 72,903 | 110,158 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 93,427 | 132,399 | 194,087 | 136,837 | 144,171 | 110,355 | 45,583 | 78,312 | 55,595 | 41,377 | 30,685 | 72,903 | 110,158 |
| net assets | 343,414 | 297,121 | 259,818 | 153,096 | 118,070 | 111,241 | 79,738 | -2,352 | -3,260 | 32,614 | 43,683 | 50,655 | 18,771 |
| total shareholders funds | 343,414 | 297,121 | 259,818 | 153,096 | 118,070 | 111,241 | 79,738 | -2,352 | -3,260 | 32,614 | 43,683 | 50,655 | 18,771 |
| May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||
| Operating Profit | |||||||||||||
| Depreciation | 0 | 0 | 1,962 | 1,962 | 1,962 | 1,520 | 1,995 | ||||||
| Amortisation | 0 | 0 | 4,000 | 4,000 | 4,000 | 4,000 | 4,000 | ||||||
| Tax | |||||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -12,960 | 1,687 | 4,636 | 747 | 2,240 | 3,650 |
| Debtors | 7,177 | -25,417 | 163,972 | 32,245 | 44,830 | 100,522 | 53,689 | 55,291 | 0 | -4,903 | -43,206 | 1,435 | 50,030 |
| Creditors | -38,972 | -61,688 | 57,250 | -7,334 | 33,816 | 64,772 | -32,729 | 22,717 | 14,218 | 10,692 | -42,218 | -37,255 | 110,158 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||
| Investing Activities | |||||||||||||
| capital expenditure | |||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||
| Financing Activities | |||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||
| interest | |||||||||||||
| cash flow from financing | |||||||||||||
| cash and cash equivalents | |||||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15,609 | -17,381 | 5,852 | -985 | -3,526 | 31,649 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15,609 | -17,381 | 5,852 | -985 | -3,526 | 31,649 |
global pharm limited Credit Report and Business Information
Global Pharm Limited Competitor Analysis
Perform a competitor analysis for global pharm limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in WF3 area or any other competitors across 12 key performance metrics.
global pharm limited Ownership
GLOBAL PHARM LIMITED group structure
Global Pharm Limited has no subsidiary companies.
Ultimate parent company
GLOBAL PHARM LIMITED
07139443
global pharm limited directors
Global Pharm Limited currently has 1 director, Mr Wajid Hussain serving since Sep 2011.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Wajid Hussain | England | 45 years | Sep 2011 | - | Director |
P&L
May 2023turnover
2.3m
+11%
operating profit
61.7k
0%
gross margin
27.5%
-3.17%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
May 2023net assets
343.4k
+0.16%
total assets
436.8k
+0.02%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
global pharm limited company details
company number
07139443
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
January 2010
age
15
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
May 2023
previous names
N/A
accountant
-
auditor
-
address
1 oakley street, thorpe, wakefield, west yorskhire, WF3 3DX
Bank
-
Legal Advisor
-
global pharm limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to global pharm limited. Currently there are 2 open charges and 0 have been satisfied in the past.
global pharm limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for GLOBAL PHARM LIMITED. This can take several minutes, an email will notify you when this has completed.
global pharm limited Companies House Filings - See Documents
| date | description | view/download |
|---|
